Indication
For treatment of chronic hepatitis C virus (HCV) infection in adults and in adolescents aged 12 to <18 years.

Medicine details

Medicine name:
glecaprevir/pibrentasvir (Maviret)
SMC ID:
SMC2214
Pharmaceutical company
AbbVie Ltd
BNF chapter
Infections
Submission type
Abbreviated
Status
Publication due date:
11 November 2019
SMC meeting date:
01 October 2019